All News #Library
Biotech
Orum Therapeutics Presents ORM-1153 Data at AACR 2026
17 Mar 2026 //
PHARMIWEB
Orum Pharma Names Chad May as Chief Scientific Officer
04 Jan 2026 //
BUSINESSWIRE
Orum Therapeutics Secures $100M for Degrader Programs
18 Dec 2025 //
PHARMIWEB
Orum Therapeutics Unveils Potent ORM-1153 Data at ASH 2025
08 Dec 2025 //
PHARMIWEB
Orum Therapeutics Presents ORM-1153 Preclinical Data at ASH 2025
03 Nov 2025 //
BUSINESSWIRE
Orum Names Dorin Toader to Lead Degrader–Antibody Platforms
15 Oct 2025 //
PHARMIWEB
Orum Therapeutics Submits Registration Statement for KOSDAQ Listing
02 Oct 2024 //
BUSINESSWIRE
Orum Announces Acquisition of ORM-6151 Program by Bristol Myers Squibb
06 Nov 2023 //
BUSINESSWIRE

Market Place
Sourcing Support